hasApprovedDrug

URI: https://gptkb.org/prop/hasApprovedDrug

105 triples

GPTKB property

approvedDrug • approvedDrugForm • firstApprovedDrug

Subject	Object
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Alectinib
gptkb:Vertex_Pharmaceuticals_Incorporated	gptkb:Trikafta
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Alpelisib
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Ramucirumab
gptkb:small_interfering_RNA_(siRNA)	Patisiran
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Regorafenib
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Lorlatinib
gptkb:t-PA	gptkb:alteplase
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Tislelizumab
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Nintedanib
gptkb:SGLT2_inhibitors	gptkb:ertugliflozin
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Gemcitabine
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Afatinib
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Ipilimumab
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Selpercatinib
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Toripalimab
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Pemetrexed
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Gefitinib
gptkb:EGFR_mutation-positive_NSCLC	gptkb:erlotinib
gptkb:erythropoietin_protein	gptkb:darbepoetin_alfa